Table of Content

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Burden of Respiratory Diseases
4.2.2 Increasing Demand for Home Healthcare Devices
4.2.3 Increasing Geriatric Population
4.3 Market Restraints
4.3.1 Drug Loss during Drug Delivery
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Portability
5.1.1 Tabletop
5.1.2 Portable
5.2 By Sales Channel
5.2.1 Direct Purchase
5.2.2 Online Purchase
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Rest of the World


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Aerogen
6.1.2 Heyer Medical AG
6.1.3 GE Healthcare
6.1.4 Abbvie Inc. (Agilent Technologies)
6.1.5 Salter Labs
6.1.6 Medline Industries Inc.
6.1.7 Briggs Healthcare
6.1.8 PARI Pharma
6.1.9 Omron Healthcare


7 MARKET OPPORTUNITIES AND FUTURE TRENDS